Regulus Therapeutics Inc.
SEC CIK 1505512 · RGLS · last insider filing 2025-06-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baltimore David | Director | filed 2012 - 2025 |
| Papadopoulos Stelios | Director | filed 2012 - 2025 |
| Rastetter William H | Director | filed 2013 - 2025 |
| Nunn Jason Raleigh | Director | filed 2019 - 2025 |
| Hagan Joseph P | Director · President and CEO | filed 2016 - 2025 |
| Klassen Preston | Director · President & Head of R & D | filed 2023 - 2025 |
| Rosen Hugh | Director | filed 2016 - 2025 |
| Witz Pascale | Director | filed 2017 - 2025 |
| Collier Kathryn J | Director | filed 2018 - 2025 |
| Huang Alice Shih-hou | Director | filed 2021 - 2025 |
| Simeonidis Simos | Director | filed 2019 - 2022 |
| Walker Paul Edward | Director | filed 2019 - 2021 |
| Foletta Mark G | Director | filed 2013 - 2017 |
| Grint Paul C | Director · President & CEO | filed 2014 - 2017 |
| Williams Douglas E | Director | filed 2012 - 2016 |
| Isis Pharmaceuticals INC | Director | filed 2012 - 2015 |
| Carter Bruce L A | Director | filed 2012 - 2015 |
| Xanthopoulos Kleanthis G | Director · President and CEO | filed 2012 - 2015 |
| Parshall B Lynne | Director | filed 2012 - 2014 |
| Greene Barry E | Director | filed 2012 - 2012 |
| Crooke Stanley T | Director | filed 2012 - 2012 |
| Maraganore John | Director | filed 2012 - 2012 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Calsada Crispina | Chief Financial Officer | filed 2019 - 2025 |
| Aker Christopher Ray | Sr. VP & General Counsel | filed 2019 - 2025 |
| Drygin Denis | Chief Scientific Officer | filed 2020 - 2022 |
| Chevallard Daniel R. | Chief Financial Officer | filed 2017 - 2019 |
| Wright Timothy Michael | Chief R & D Officer | filed 2016 - 2019 |
| Deeg Mark Albert | Chief Medical Officer | filed 2017 - 2018 |
| Gibson Neil W | Chief Scientific Officer | filed 2012 - 2015 |
| Szekeres David Leslie | See Remarks | filed 2014 - 2014 |
| Menzel Garry E | COO & Executive VP, Finance | filed 2012 - 2012 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.